Efficacy of BIBF 1120 or BIBF 1120 plus chemotherapy on nasopharyngeal carcinoma in vitro and in vivo

PURPOSE: BIBF 1120 is a potent triple angiokinase inhibitor now being evaluated in many types of tumors. We examine the antitumor effects of BIBF 1120 on nasopharyngeal carcinoma (NPC) in vitro and in vivo. MATERIALS AND METHODS: The effect of BIBF 1120 on NPC cell proliferation was evaluated using...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Drug Des Devel Ther
Egile Nagusiak: Xue, Cong, Tian, Ying, Zhang, Jing, Zhao, Yuanyuan, Zhan, Jianhua, Fang, Wenfeng, Zhang, Li
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2016
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4801128/
https://ncbi.nlm.nih.gov/pubmed/27042009
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S96634
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak